SJL Partners LLC

Overview

SJL Partners LLC is a private equity investment manager based in Seoul, South Korea, established in 2017. The firm specializes in cross-border investments, primarily targeting opportunities in North America and Europe, in partnership with strategic investors from Asia. This approach aims to leverage synergies and mitigate risks by combining SJL's expertise in cross-border mergers and acquisitions with the capabilities of its strategic partners. The firm's investment strategy encompasses various stages, including buyouts, growth, late-stage, and pre-IPO investments. SJL Partners has a diverse portfolio across multiple industries, such as life sciences, battery technology, chemicals, fashion, and healthcare. Notable investments include Meridian Bioscience, a U.S.-based life science company; Nexeon, a UK-based leader in silicon anode materials for rechargeable batteries; Momentive Performance Materials, a global producer of specialty silicones; and Celltrion Holdings, a South Korean biopharmaceutical company. SJL Partners' philosophy centers on achieving win-win outcomes for all stakeholders by serving as an enabler to portfolio companies. The firm focuses on key pivot points that make a difference while balancing financial prudence with smart capital deployment. This approach has been instrumental in facilitating significant transactions, such as the joint acquisition of Meridian Bioscience with SD Biosensor in 2023 and the investment in Nexeon and NSC with SKC in 2022.

Investment Focus

• Partnership with strategic investors from Asia
• Focus on cross-border opportunities in North America and Europe
• Emphasis on value creation through synergies and risk mitigation

Portfolio Companies